Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Identification of Acute Myeloid Leukemia Cell Surface Therapeutic Targets Using Single Cell RNA Sequencing Supported By Surface Proteomics

Blood (2023) 142 (Supplement 1): 163.

https://doi.org/10.1182/blood-2023-186367

Published: 2023

Journal Articles

IL1R1 Expression Predicts the Benefit from Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Intermediate-Risk Cytogenetics

Guillaume Richard-Carpentier, Francois Beliveau, Sandrine Lacoste, Jean-Francois Spinella, Michael Vladovsky, Patrick Gendron, Sébastien Lemieux, Vincent-Philippe Lavallee, Guy Sauvageau, Josee Hebert

Blood (2022) 140 (Supplement 1): 6333–6334.

https://doi.org/10.1182/blood-2022-170230

Published: 2022

Journal Articles

Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML

Blood (2019) 134 (3): 263–276.

https://doi.org/10.1182/blood.2018862383

Published: 2019

Includes: Supplemental data

Journal Articles

Chemo-Transcriptomic Analysis of Complex Karyotype AML Reveals Increased Expression of Cell Cycle Components and Exquisite Dependency on Polo-like Kinase 1

Vincent-Philippe Lavallée, MD, Clarisse Thiollier, PhD, Céline Moison, PhD, Marie-Ève Bordeleau, PhD, Isabel Boivin, M.Sc, Geneviève Boucher, M.Sc, Patrick Gendron, M.Sc, Sébastien Lemieux, PhD, Anne Marinier, PhD, Josée Hébert, MD, Guy Sauvageau, MD, PhD

Blood (2016) 128 (22): 769.

https://doi.org/10.1182/blood.V128.22.769.769

Published: 2016

Journal Articles

Transcriptional Landscape of APL Identifies Aberrant Podoplanin Expression As a Defining Feature and Missing Link for the Bleeding Disorder of This Disease

Vincent-Philippe Lavallée, MD, Miriam Marquis, PhD, Marie-Ève Bordeleau, PhD, Jalila Chagraoui, PhD, Tara MacRae, M.Sc., Isabel Boivin, M.Sc, Geneviève Boucher, M.Sc, Patrick Gendron, M.Sc, Sébastien Lemieux, PhD, Arnaud Bonnefoy, PhD, Georges E. Rivard, MD, Josée Hébert, MD, Guy Sauvageau, MD, PhD

Blood (2016) 128 (22): 1075.

https://doi.org/10.1182/blood.V128.22.1075.1075

Published: 2016

Journal Articles

Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors

Vincent-Philippe Lavallée, Jana Krosl, Sébastien Lemieux, Geneviève Boucher, Patrick Gendron, Caroline Pabst, Isabel Boivin, Anne Marinier, Cynthia J. Guidos, Sylvain Meloche, Josée Hébert, Guy Sauvageau

Blood (2016) 127 (24): 3054–3061.

https://doi.org/10.1182/blood-2016-03-705053

Published: 2016

Includes: Supplemental data

Journal Articles

RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature

Vincent-Philippe Lavallée, Sébastien Lemieux, Geneviève Boucher, Patrick Gendron, Isabel Boivin, Richard N. Armstrong, Guy Sauvageau, Josée Hébert

Blood (2016) 127 (20): 2498–2501.

https://doi.org/10.1182/blood-2016-03-703868

Published: 2016

Includes: Supplemental data

Journal Articles

GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo

Blood (2016) 127 (16): 2018–2027.

https://doi.org/10.1182/blood-2015-11-683649

Published: 2016

Includes: Supplemental data

Journal Articles

Mutational and Transcriptomic Landscape of AML with Core-Binding Factor Rearrangements

Vincent-Philippe Lavallée, MD, Patrick Gendron, M.Sc, Geneviève Boucher, M.Sc, Sébastien Lemieux, PhD, Richard Neil Armstrong, PhD, Isabel Boivin, M.Sc, Guy Sauvageau, MD, PhD, Josée Hébert, MD

Blood (2015) 126 (23): 802.

https://doi.org/10.1182/blood.V126.23.802.802

Published: 2015

Journal Articles

The Novel Leukemia Stem Cell Marker GPR56 Discriminates Leukemic Subclones with Divergent Stem Cell Properties in Human Acute Myeloid Leukemia

Caroline Pabst, MD, Anne Bergeron, PhD, Vincent-Philippe Lavallée, MD, Jonathan Yeh, PhD, Patrick Gendron, M.Sc, Jana Krosl, PhD, Geneviève Boucher, M.Sc, Sébastien Lemieux, PhD, Josee Hébert, MD, Guy Sauvageau, MD, PhD, Frédéric Barabé, MD

Blood (2015) 126 (23): 1859.

https://doi.org/10.1182/blood.V126.23.1859.1859

Published: 2015

Journal Articles

EVI1 -rearranged acute myeloid leukemias are characterized by distinct molecular alterations

Vincent-Philippe Lavallée, Patrick Gendron, Sébastien Lemieux, Giovanni D’Angelo, Josée Hébert, Guy Sauvageau

Blood (2015) 125 (1): 140–143.

https://doi.org/10.1182/blood-2014-07-591529

Published: 2015

Includes: Supplemental data

Journal Articles

NGS-Based Detection Of Multiple RAS -Mutated Clones In MLL -Rearranged Leukemias Suggests Strong Oncogenic Collaboration

Vincent-Philippe Lavallée, MD, Patrick Gendron, M.Sc., Geneviève Boucher, M.Sc., Marianne Arteau, M.Sc., Brian T Wilhelm, Ph.D., Sébastien Lemieux, Ph.D., Josée Hébert, MD, Guy Sauvageau, MD, PhD

Blood (2013) 122 (21): 744.

https://doi.org/10.1182/blood.V122.21.744.744

Published: 2013

Journal Articles

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

Hiba A Zahreddine, Biljana Culjkovic-Kraljacic, PhD, Sarit Assouline, MD, Abdellatif Amri, Patrick Gendron, M.Sc., Andrea A. Romeo, PhD, Stephen Morris, PhD, James Jaquith, PhD, Gregory Cormack, Eftihia Cocolakis, PhD, Julie Bergeron, MD, Leandro Cerchietti, MD, Brian Leber, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB. Borden, PhD

Blood (2013) 122 (21): 821.

https://doi.org/10.1182/blood.V122.21.821.821

Published: 2013

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Identification of Acute Myeloid Leukemia Cell Surface Therapeutic Targets Using Single Cell RNA Sequencing Supported By Surface Proteomics

IL1R1 Expression Predicts the Benefit from Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Intermediate-Risk Cytogenetics

Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML

Chemo-Transcriptomic Analysis of Complex Karyotype AML Reveals Increased Expression of Cell Cycle Components and Exquisite Dependency on Polo-like Kinase 1

Transcriptional Landscape of APL Identifies Aberrant Podoplanin Expression As a Defining Feature and Missing Link for the Bleeding Disorder of This Disease

Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors

RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature

GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo

Mutational and Transcriptomic Landscape of AML with Core-Binding Factor Rearrangements

The Novel Leukemia Stem Cell Marker GPR56 Discriminates Leukemic Subclones with Divergent Stem Cell Properties in Human Acute Myeloid Leukemia

EVI1 -rearranged acute myeloid leukemias are characterized by distinct molecular alterations

NGS-Based Detection Of Multiple RAS -Mutated Clones In MLL -Rearranged Leukemias Suggests Strong Oncogenic Collaboration

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only